Peak Bio (PKBO)
US Market

Peak Bio (PKBO) Stock Price & Analysis


PKBO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.47 - $15.00
Previous Close$0.95
Average Volume (3M)2.31K
Market Cap
Enterprise Value$15.17M
Total Cash (Recent Filing)$75.97K
Total Debt (Recent Filing)$399.38K
Price to Earnings (P/E)-7.0
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding20,058,486
10 Day Avg. Volume3,683
30 Day Avg. Volume2,306
Standard Deviation0.19
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-6.86
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Peak Bio’s price range in the past 12 months?
Peak Bio lowest stock price was $0.47 and its highest was $15.00 in the past 12 months.
    What is Peak Bio’s market cap?
    Currently, no data Available
    When is Peak Bio’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Peak Bio’s earnings last quarter?
    Currently, no data Available
    Is Peak Bio overvalued?
    According to Wall Street analysts Peak Bio’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Peak Bio pay dividends?
      Peak Bio does not currently pay dividends.
      What is Peak Bio’s EPS estimate?
      Peak Bio’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Peak Bio have?
      Peak Bio has 19,782,747 shares outstanding.
        What happened to Peak Bio’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Peak Bio?
        Among the largest hedge funds holding Peak Bio’s share is Deerfield Management Company, LP. It holds Peak Bio’s shares valued at 7M.


          Peak Bio Stock Smart Score

          This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
          Learn more about TipRanks Smart Score

          Company Description

          Peak Bio

          Ignyte Acquisition Corp is a blank check company.


          Forecast EPS vs Actual EPS

          Currently, no data available
          Please return soon. This page is being updated.

          Similar Stocks
          Price & Change
          Annovis Bio
          ImmunoCellular Therapeutics
          Capricor Therapeutics
          Praxis Precision Medicines

          Popular Stocks

          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis